Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
2004
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein
1992 StandoutNatureNobel
Lack of an effect of dairy protein (casein) and soy protein on plasma cholesterol of strict vegetarians. An experiment and a critical review.
1983
Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
1996
Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine.
1984
Intake of 25 g of Soybean Protein with or without Soybean Fiber Alters Plasma Lipids in Men with Elevated Cholesterol Concentrations
1994
Phytoestrogens — a short review
1995
Progress and challenges in anti-obesity pharmacotherapy
2017
Effects of soy protein and casein in low cholesterol diets on plasma lipoproteins in normolipidemic subjects
1988
Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers
1993
Current and Investigational Antiobesity Agents and Obesity Therapeutic Treatment Targets
2004
Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials
2003
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Bariatric Surgery
2004 Standout
Beyond Cholesterol
1989 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients.
1987
Apoptosis: controlled demolition at the cellular level
2007 Standout
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
2004 Standout
Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society
2005
Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia
1991
Cell Death
2004 Standout
INTENSIVE THERAPIES FOR PEDIATRIC OBESITY
2001
Depression of plasma cholesterol in men by consumption of baked products containing soy protein
1993
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
2006 Standout
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Obesity
2005 Standout
What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions
2004
Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials
2004
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial or polygenic hypercholesterolemia
1993
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Contrast‐enhanced first pass myocardial perfusion imaging: Correlation between myocardial blood flow in dogs at rest and during hyperemia
1993
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Long-term effects of weight-reducing diets in hypertensive patients
2011
ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine.
2000
Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease
2003
Long-term effects of weight-reducing drugs in hypertensive patients
2009
Long‐term changes in blood pressure following orlistat and sibutramine treatment: a meta‐analysis
2009
Long-term effects of weight-reducing drugs in hypertensive patients
2013
Effects of fibrates on serum lipids and atherosclerosis
1988
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
1999
Pravastatin Has Cholesterol-Lowering Independent Effects on the Artery Wall of Atherosclerotic Monkeys
1998
BEHAVIORAL THERAPY IN THE TREATMENT OF PEDIATRIC OBESITY
2001
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis
2009
Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice
2005
Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity
2008
CED-1 Is a Transmembrane Receptor that Mediates Cell Corpse Engulfment in C. elegans
2001 StandoutNobel
Dietary treatment for familial hypercholesterolemia—differential effects of dietary soy protein according to the apolipoprotein E phenotypes
1991
The Laparoscopic Adjustable Gastric Band (Lap-Band<SUP>®</SUP>): A Prospective Study of Medium-Term Effects on Weight, Health and Quality of Life
2002
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Ghrelin: Structure and Function
2005 Standout
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
2000 Standout
Soy Protein, Isoflavones and Cardiovascular Disease Risk
1998
Atherosclerosis
2001 Standout
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
1998 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Effects of Weight Loss in Overweight/Obese Individuals and Long-Term Hypertension Outcomes
2005
Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function.
1981
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Soybean protein independently lowers plasma cholesterol levels in primary hypercholesterolemia
1982
Soy protein and casein in cholesterol-enriched diets: effects on plasma lipoproteins in normolipidemic subjects
1989
Screening and Interventions for Obesity in Adults: Summary of the Evidence for the U.S. Preventive Services Task Force
2003
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Soy Protein and Cardiovascular Disease
2000
Pharmacological Approaches for the Treatment of Obesity
2002
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Soy Protein, Isoflavones, and Cardiovascular Health
2006
Constancy of fasting serum cholesterol of healthy young women upon substitution of soy protein isolate for meat and dairy protein in medium and low fat diets
1986
Pharmacological and surgical treatment of obesity.
2004
Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications
2002
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses
1996 Standout
Application of digital techniques to selective coronary arteriography: Use of myocardial contrast appearance time to measure coronary flow reserve
1984
Statins for the primary prevention of cardiovascular disease
2013
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Inflammation and Atherosclerosis
2002 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Albumin-Deficient Rat Mutant
1979 Science
Soybean protein diets in the management of type II hyperlipoproteinaemia
1985
Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease
2004
Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function
1999 Standout
Validation in dogs of a rapid digital angiographic technique to measure relative coronary blood flow during routine cardiac catheterization
1985
A comparison of the effect of diets containing beef protein and plant proteins on blood lipids of healthy young men
1984
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Review of clinical studies on cholesterol-lowering response to soy protein
1991
Lipoprotein-antibody immune complexes their catabolism and role in foam cell formation
1985
Turnover of very low-density lipoprotein-apoprotein B is increased by substitution of soybean protein for meat and dairy protein in the diets of hypercholesterolemic men
1984
Long-term pharmacotherapy for obesity and overweight
2003
Fractional Flow Reserve
1995
The Biology and Detection of Immune Complexes
1980
Long-term Drug Treatment for Obesity
2013
TIMI Frame Count
1996 Standout
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults
2018
A Randomized Trial Comparing the Effect of Casein With That of Soy Protein Containing Varying Amounts of Isoflavones on Plasma Concentrations of Lipids and Lipoproteins
1999
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits
1987
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of G Noseda being referenced
Hypo‐β‐Lipoproteinaemia Associated with Auto‐Antibodies Against β‐Lipoproteins
1972
Antibodies against lipoproteins in man occurrence and biological significance
1975
Weight Loss, Weight Maintenance, and Improved Cardiovascular Risk Factors after 2 Years Treatment with Orlistat for Obesity
2000
Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II
1990
Reverse Cholesterol Transport in Plasma of Patients With Different Forms of Familial HDL Deficiency
1995
Cholesterol-Lowering and HDL-Raising Properties of Lecithinated Soy Proteins in Type II Hyperlipidemic Patients
1985
Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
1995
BLOOD FLOW MEASUREMENT THROUGH SINGLE CORONARY ARTERIES BY ROENTGEN DENSITOMETRY
1970
Hypercholesterolaemia treated by soybean protein diet.
1987
[Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study].
1993
MULTICENTRE STUDY OF SOYBEAN PROTEIN DIET FOR OUTPATIENT HYPERCHOLESTEROLÆMIC PATIENTS
1980
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I
1998
[Clinical trial of tibric acid, a new hypolipidemic agent].
1974
[Analbuminemia. Pathophysiological study of a case].
1972
Blood flow measurement through single coronary arteries by roentgen densitometry. I. A comparison of flow measured by a radiologic technique applicable in the intact organism and by electromagnetic flowmeter.
1970
Fecal cholesterol excretion studies in type II hypercholesterolemic patients treated with the soybean protein diet
1982
Anti‐β‐Lipoprotein Activity of Human Monoclonal Immunoglobulins
1972